http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11953989

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 726
issn 1432-0584
0939-5555
issueIdentifier 9
pageRange 717-726
publicationName Annals of Hematology
startingPage 717
bibliographicCitation Zwick C, Birkmann J, Peter N, Bodenstein H, Fuchs R, Hänel M, Reiser M, Hensel M, Clemens M, Zeynalova S, Ziepert M, Pfreundschuh M; German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL). Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone). Ann Hematol. 2008 Sep;87(9):717–26. doi: 10.1007/s00277-008-0500-1. PMID: 18587579.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4abadc556052a11d5d77c4354fee41e7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_573f3f03e660b3c9a813c152c4a68483
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ec87466cdbc65d1738026fa0f4c3a2a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8458e391c0fc9e285e922cc61d3e0d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a742584cdceb1bb4cc455d13eeb2c29
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3ab036059ce7dbf8deceaca1cc8b21f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce34bcd80b8c03788e10c29dcbcbcf01
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d204261f85f31992d2f0e1e1e6fc774a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe13a9db51ddcc88c821b6f5ba174ee6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d784fe90c97975ebeb016ba4b24d4cc2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c4fe7ec3ad37f8502e6599d6694c670
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e9ab0da0a1cb7ad207b682675718d07
date 2008-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s00277-008-0500-1
https://pubmed.ncbi.nlm.nih.gov/18587579
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1088
https://portal.issn.org/resource/ISSN/0939-5555
https://portal.issn.org/resource/ISSN/1432-0584
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Equitoxicity of bolus and infusional etoposide: results of a multicenter randomised trial of the German High-Grade Non-Hodgkins Lymphoma Study Group (DSHNHL) in elderly patients with refractory or relapsing aggressive non-Hodgkin lymphoma using the CEMP regimen (cisplatinum, etoposide, mitoxantrone and prednisone)
discusses http://id.nlm.nih.gov/mesh/M0007930
http://id.nlm.nih.gov/mesh/M0017465
http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0001486
http://id.nlm.nih.gov/mesh/M0013954
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460033
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128397534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275

Total number of triples: 49.